Success Stories: NAILG Achieves EB1A Approval for Researcher Advancing Immunotherapy and Vaccine Science
Client’s Testimonial:
“NAILG was incredibly responsive in communication—they guided me on how to prepare materials, helped organize them thoroughly, and got my EB-1A approved in just 1 year. Their efficiency was impressive!”
On January 15th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Research Scientist in the field of Biomedical Science (Approval Notice).
General Field: Biomedical Science
Position at the Read more [...]